Acute lung injury/acute respiratory distress syndrome (ALI/ARDS) are life-threatening condition in critically ill patients. Resveratrol (Res), a natural polyphenol, has therapeutic effect in animal model with ALI; however, whether Res attenuates ALI through modulation of macrophage phenotypes in the animal model remains unknown. We in this study treated LPS-induced murine ALI with 30 mg/kg Res and observed significantly reduced severity of ALI in the Res-treated mice 48 hours after Res treatment.
lung tissues and blood circulation, sharing different cell subtypes.
The different macrophage subtypes exclusively release high amount of pro-inflammatory, anti-inflammatory cytokines and chemokines, participating in the pathogenesis of ALI/ARDS, asthma and other inflammatory lung diseases. 2, 3 There are no effective therapeutics for ARDS so far. Patients are usually treated with low tidal volume ventilation and fluid restriction, 4 high dose of corticosteroid 5 and antioxidants, such as N-acetylcysteine. 6 However, the therapeutic approaches produced elusive therapeutic effects and did not improve patient survival rate. Thus, it is essential to explore novel and more effective therapeutics for ARDS.
Resveratrol (Res), a phytoalexin antioxidant from red grapes, has anti-inflammatory properties. 7, 8 Studies in vivo have confirmed that Res can attenuate the severity of ALI in animal models. 9, 10 Res or Res-curcumin hybrids can significantly attenuate disease severity of ALI, accompanied with lower production of pro-inflammatory cytokines and chemokines, such as TNF-alpha, IL-1beta, IL-6, IL-12, IL-33, MIP-2 and IL-18. In contrast, the anti-inflammatory cytokines and molecular mediators, such as IL-10, heme oxygenase-1 (HO-1),Nrf2
(nuclear factor-erythroid 2 related factor) and SOD (superoxide dismutase), were increased in the Res-treated animal models. 10, 11 The beneficial effects may be associated with up-regulation and activation of SIRT1, a nicotinamide adenine dinucleotide (NAD+dependent deacetylase sirtuin 1). 12 It was reported that SIRT1 has multiple biological functions on variable cells, by suppressing cell activation, preventing cell senescence, etc. A variable signalling pathways are involved in the beneficial effects, such as NF-kappa B and JAK/STAT signalling pathway 7 and PI3K/Nrf2/HO-1 signalling pathway. 10 In the Res-treated cells, the levels of pro-inflammatory cytokines (TNF-alpha, IL-1beta, IL-6) and chemokines (CCL2/MCP-1, CCL4/MIP-1beta, CCL5/RANTES, CXCL10/IP-10) were significantly suppressed. 13 However, knockdown of SIRT1 diminished the antiinflammatory effects of Res, indicating the critical role of SIRT1 in the Res-mediated suppression of inflammation. 14 Furthermore, Res may suppress inflammation through inducing macrophages pyroptosis and apoptosis. 15, 16 Therefore, Res has variable biological function on cells.
IL-6 and IL-22 induce activation of signal transducer and activator of transcription-3 (STAT3) through acetylation in lysine (Lys)685 and phosphorylation in tyrosine (Tyr)705 residues, but activation of STAT3 is suppressed by SIRT1, a class III deacetylase. 17, 18 More activation of STAT3 induces more expression of cytokine expression. Blocking STAT3 activation by small-molecule STAT3 inhibitor (LLL12) can suppress the expression of IL-1beta, IL-6, TNF-alpha, iNOS, CCL2 and MHC class II in macrophages and inflammatory cells from LPS-induced ALI mouse model, indicating the pro-inflammatory function of STAT3. 19 It is known that SOCS3 is a negative regulator of STAT3. Activation of STAT3 induces transcriptional up-regulation of SOCS3 and subsequently suppresses STAT3 activation in the inflammatory condition. The negative feedback loop of STAT3/SOCS3 signalling has important implication in overcoming excessive tissue inflammation and preventing tissue damage during inflammatory immune responses. 17, 20 Our previous study and report from other group 21 indicated that STAT3/SOCS3 signalling suppressed macrophage polarization and activation in the murine ALI mouse model, whereas disruption of STAT3/SOCS3 signalling in SOCS3 myeloid cell-restricted conditional knock-out mice (cKO) significantly enhanced the severity of LPS-induced ALI and sepsis, accompanied with high expression of M1 cell genes (IL-1beta, IL-6, IL-12, IL-23,   inducible NO synthase) . 2, 20 However, to our knowledge, whether Res attenuated ALI through macrophage STAT3/SOCS3 signalling remains undefined. In this study, we treated LPS-induced murine ALI in WT and cKO mice with Res. The results revealed that Res can significantly attenuate the severity and neutrophil infiltration of murine ALI dependent on SOCS3 expression in macrophages. The beneficial results were associated with more CD45 + CD206 + biased M2 macrophage polarization and less infiltration of CD45 + Siglec F − phenotype macrophages. The results revealed the important role of macrophage STAT3/SOCS3 signalling in the Res-mediated therapy of ALI.
| MATERIAL AND ME THODS

| Animal procedure
Eight-to ten-week-old male wild-type (WT) C57BL/6 mice were obtained from the Shanghai Biomodel Organism Science & Technology.
Animal protocol was reviewed and approved by the laboratory animal care and use committee of Zhongshan Hospital, Fudan University. All animal experiments were performed in the Zhongshan Hospital, Fudan University. SOCS3 cKO were obtained by breeding SOCS3fl/fl mice with Lyz2-Cre transgenic mice under the control of myeloid cell-restricted lysozyme 2 (Lyz2) promoter, and the mice with SOCS3 −/− phenotype were used for this study. 2 
| Isolation and culture of bone marrow-derived macrophages (BMDMs)
To isolate murine BMDMs, bone marrow cells were flushed from the femurs and tibiae of WT or cKO mice. These cells werecultured in RPMI 1640 medium containing 10% FBS and 20 ng/mL of murine M-CSF (PeproTech) for 7 days to obtain BMDMs. Cell purity was determined by FACS analysis for CD11b and F4/80 (>96%). The cells were pre-treated with indicated concentration of Res 1 hour prior to LPS 500 ng/mL treatment for 24 hours. The untreated cells and the cells treated Res and LPS alone were used as controls. Gene and protein expression in the treated cells were analysed by qRT-PCR, Western blot analysis.
| Flow cytometry
Lung digests were obtained by incubation with 1 mg/mL collagenase A, and 100 ng/mL DNase (Sigma) for 1 hour. 0.5-1 × 10(6) cells from lung digests and BAL were stained with cell surface antibodies including PerCP-cy5.5-conjugated anti-F4/80, PE-Cy7-conjugated anti-Ly6G, PE-conjugated anti-CD45, BV421-conjugated anti-Siglec F and APC-conjugated anti-CD206 (BioLegend). Analysis was performed on FACScan cytometer (Becton Dickinson). All data were analysed on FlowJo software (Tree Star).
| ELISA assay for cytokines
IL-1beta and CXCL15 protein concentration in BAL and lung digests were measured by ELISA kit according to the manufacturer's instructions (R&D systems Inc).
| Western blot analysis
The concentration of acetylated and phosphorylated STAT3, total STAT3 and SIRT1 protein in lung tissue extracts and macrophage lysates were analysed by Western blot analysis. The procedure was previously described. 2 Primary antibodies for Western blot analysis include rabbit anti-total STAT3 (Clone: 79D7), rabbit anti-phosphorylated STAT3 at residue Tyr-705, rabbit anti-acetylated STAT3 at residue Lys-685, rabbit anti-SIRT1 (Hangzhou HuaAn Biotech). The antimouse GAPDH antibody was used as a loading control. The blots were washed with TBST buffer and incubated with horseradish peroxidase (HRP)-conjugated anti-rabbit immunoglobulin (Ig) and then developed with ECL substrate solution (Amersham Biosciences). Protein expression was quantitatively analysed on ImageJ software by the ratio of densitometric intensity of target protein to internal control GAPDH.
| Immunostaining assay
Acetylated STAT3 expression and SIRT1 expression in the lung tissues of treated mice and cells were analysed by immunostaining assay. Briefly, lung tissue sections and cells were fixed with 4% paraformaldehyde, followed by incubation with 0.05% Triton X-100 and blocking buffer (10% goat serum in PBS). The sections and cells were incubated with first antibody rabbit anti-acetylated STAT3 and SIRT1 (1:200 dilution) for 3 hours and followed by secondary antibody HRP-conjugated anti-rabbit IgG or Cy3-conjugated anti-rabbit IgG (1:500 dilution) for 2 hours. The positive cells were developed by 3,3'-diaminobenzidine (DAB) and visualized under contrast microscope or fluorescence microscope.
| Quantitative RT-PCR (qRT-PCR)
CXCL15, IL-1beta IL-6, SIRT1, arginase-1, iNOS and SOCS3 mRNA transcripts in lung tissues and cells were analysed by qRT-PCR as previously described. 2 The primer sequences were listed in Table 1 .
The relative gene expression was analysed using the 2 −ΔΔCT method.
| Statistical analysis
Results are presented as mean ± standard error (SE) for each group.
Student's t test was used to determine statistical significance between two groups. One-way analysis of variance (ANOVA) followed by Tukey's multiple comparisons test was performed for parametric multivariable analysis on GraphPad Prism 7 software. The data were considered statistically significant for P values < .05. Figure 1A,B ). Consistent with the results above, the total cell counts ( Figure 1C ), absolute number of neutrophils ( Figure 1D) and percentage of CD3 + CD4 + T cells ( Figure 2A ) were significantly increased in BAL of mice with ALI, but they were markedly reduced in the mice co-treated with Res and LPS.
| RE SULTS
| Res attenuated acute lung inflammation in mice with LPS-induced ALI
To further investigate the changes of lung macrophages and subtypes associated with ALI suppression by Res, we analysed macrophages and their phenotypes in the treated mice. 
| Depletion of M2 macrophages prevented Res-induced attenuation of ALI
| Res attenuated pro-inflammatory cytokine expression and activation of STAT3
CXCL15 attracts neutrophils into the inflamed sites, favouring pro-inflammatory M1 macrophage polarization. 22 To investigate whether these mediators are modulated by Res, we measured IL-1beta and CXCL5 expression in the lung tissues by ELISA ( Figure 4A 
| Res attenuated ALI by STAT3/SOCS3 signalling pathway
Our previous study indicated that STAT3/SOCS3 signalling pathway played an important regulatory role in the progression of ALI. 3 To investigate whether Res suppresses ALI through STAT3/ SOCS3 signalling, we compared the therapeutic effects of Res in WT and cKO mice, in which SOCS3 was myeloid cell-restricted depleted. The mice untreated, Res or LPS treated alone were used as naïve or untreated controls. The results revealed that LPS i.t.
induced more lung inflammation and injury in cKO mice than those of WT mice as previously reported. 3 Though Res can effectively suppress the severity of ALI and lung inflammation in WT mice, myeloid cell-restricted lack of SOCS3 prevented the suppressive effects of Res on cKO mice with ALI ( Figure 5A-B) . The results Data were presented as mean ± standard error, n = 5, *P < .05 vs LPS group. E, M1 and M2 subtype macrophages in lung digests and CXCL15 protein expression in BAL were, respectively, analysed by flow cytometry and ELISA analysis. Data were presented as mean ratio of M1/M2 and expression of CXCL15 ± standard error, n = 5, *P < .05 vs LPS group were consistent with the results of total cell counts ( Figure 5C ) and absolute number of neutrophils ( Figure 5D ) in BAL. Flow cytometry analysis showed that the percentage of F4/80(low)Ly6G + phenotype neutrophils in BAL and lung tissues in WT mice with ALI were significantly suppressed, but not in those of cKO mice ( Figure 5E ). More studies on macrophage subtypes by flow cytometry showed that the population of CD45 + Siglec F − subtype infiltrating macrophages was significantly reduced in the lung of Res-treated WT mice with ALI (P < .05), but not in the lung of cKO mice with ALI ( Figure 5F ). Furthermore, we observed the heightened ratio of M2/M1 subtype macrophages in the Res-treated WT mice, but not altered in the Res-treated cKO mice ( Figure 5G ).
Therefore, myeloid cell-restricted SOCS3 deficiency prevented
Res-mediated suppression of ALI through STAT3/SOCS3 signalling pathway.
To further investigate whether pro-inflammatory cytokines and other mediators were affected by Res treatment in cKO mice, we measured CXCL15 and IL-1beta expression by ELISA assay.
The results showed a significantly reduced expression of CXCL15 and IL-1beta expression at protein ( Figure 6A 
| Res suppressed M1 cell-biased polarization of BMDMs from WT mice, but not from cKO mice
To further confirm whether the suppressive effects of Res in murine ALI are mediated by STAT3/SOCS3 signalling in macrophages, we treated BMDMs with different concentrations of Res. The results indicated that LPS activated STAT3, inducing phosphorylation and acetylation of STAT3, but the STAT3 activation was moderately suppressed by Res treatment in BMDMs ( Figure 7A-C) . Because SOCS3 is a negative feedback regulator of STAT3, our further analysis by Western blot and qRT-PCR analysis revealed that Res largely up-regulated expression of SOCS3 in BMDMs, that was negatively correlated to the suppression of STAT3 (Figure 7A,D) . In addition, we observed lower expression of IL-6 and CXCL15 ( Figure 7E ), but higher expression of SIRT1 and arginase-1 ( Figure 7C It is documented that SIRT1 is critically involved in variable cell biological function. [22] [23] [24] Loss of SIRT1 in SIRT1 knock-out mice delayed locomotor recovery, in association with more expression of pro-inflammatory cytokines and population of M1 type macrophages in a mouse model with spinal cord injury. 25 Consistent with the previous report, 22 we observed that Res up-regulated the expression of SIRT1, whereas LPS moderately reduced the expression of SIRT1 in BMDMs. The results were consistent with previously reports, in which there was lower SIRT1 expression in the inflammatory lungs of animal models with LPS-induced ALI and pulmonary contusion. [26] [27] [28] However, our further study indicated that co-treatment of BMDMs with both Res and LPS prevented the LPS-induced suppression of SIRT1 ( Figure 7C) In conclusion, this study indicated that Res suppressed lung inflammation of mice with LPS-induced ALI, in association with significantly reduced neutrophil infiltration and production of F I G U R E 8 Schematic diagram of resveratrol (Res)-mediated suppression of ALI through STAT3/SOCS3 signalling. LPS induces oxidative stress and activates STAT3, subsequently induces IL-6, IL-1beta and CXCL15 expression, ultimately causes ALI/ARDS. Activation of STAT3 up-regulates expression of SOCS3 that negatively suppresses STAT3 signalling-mediated pro-inflammatory cytokine expression and maintains a balance between pro-inflammatory and anti-inflammatory responses. Res increases the expression and activation of anti-inflammatory SIRT1 and SOCS3, subsequently lead to lower expression of IL-6, IL-1beta and CXCL15
pro-inflammatory cytokines. Res significantly modulated macrophage activation and polarization, with enhanced polarization of anti-inflammatory M2 and CD45 + Siglec F + subtype macrophages by Res treatment. STAT3/SOCS3 signalling critically participated in macrophage polarization and mediated the suppressive effects of Res in mice with ALI ( Figure 8 ). Thereby, this study gained insights into a new role and underlying molecular mechanisms of Res in the therapy of murine ALI. The results provided a solid molecular basis for application of Res to clinical trial in the future.
| CLINI C AL PER S PEC TIVE S
• Res has anti-inflammatory and antioxidant effects. Previous studies showed that Res attenuated the severity of ALI in animal models, associated with lower expression of pro-inflammatory cytokines.
However, whether SOCS3 signalling pathway in macrophages is involved in the attenuation of ALI remains unknown.
• In this study, we compared the effects of Res on lung inflammation of murine ALI and macrophage phenotypes in WT and SOCS3 cKO mice. The results revealed that Res suppressed lung inflammation in murine ALI, associated with the suppressed CD45 + Siglec F − and CD45 + CD206 − M1 subtype macrophages, but increased CD45 + Siglec F + and CD45 + CD206 + M2 subtype macrophages in murine ALI.
However, the effects were not observed in SOCS3 cKO mice.
• The results gained insights into the important role of STAT3/ SOCS3 signalling in polarization of CD45 + Siglec F − subtype and CD45 + CD206 − M1 subtype macrophages, as well as resveratrol-mediated attenuation of lung inflammation in murine ALI.
Therefore, modulation of macrophage subtypes by targeting SOCS3 signalling is a promising therapeutic approach in the treatment of murine ALI and patients with ARDS in the future.
